A Double-Blind Controlled Evaluation of Actifed? and its Individual Constituents in Allergic Rhinitis

John T Connell; Benjamin O Williams; Sue Allen; Allen Cato; J Greg Perkins

首页> 外文期刊>Journal of International Medical Research >A Double-Blind Controlled Evaluation of Actifed? and its Individual Constituents in Allergic Rhinitis

【24h】

A Double-Blind Controlled Evaluation of Actifed? and its Individual Constituents in Allergic Rhinitis

机译：主动式双盲控制评估？变应性鼻炎及其个体成分

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Pseudoephedrine and triprolidine, administered every 6 hours as a combination, made separate and distinct contributions to the treatment of allergic rhinitis. Furthermore, the combination was perceived by the patients as being clinically superior to either of its components or placebo.

机译：每6小时联合使用伪麻黄碱和曲普利啶，对变应性鼻炎的治疗有各自不同的贡献。此外，患者认为该组合在临床上优于其组分或安慰剂。

著录项

来源
《Journal of International Medical Research》 |1982年第5期|共7页
作者
John T Connell; Benjamin O Williams; Sue Allen; Allen Cato; J Greg Perkins;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis [J] . Mi-Kyeong Kim, Sook Young Lee, Hae-Sim Park, Clinical therapeutics . 2018,第7期

机译：随机，多中心，双盲，第三阶段研究，以评估哮喘和过敏性鼻炎术患者蒙特洛斯特和左甲基嗪的联合鼻炎和安全性的疗效
2. Pollen Low dose Intradermal Therapy Evaluation (PollenLITE): A double-blind randomised controlled trial of low-dose intradermal grass pollen immunotherapy in seasonal allergic rhinitis [J] . Slovick A., Douiri A., Lam E., Clinical and experimental allergy : . 2015,第12期

机译：花粉低剂量皮内治疗评估（PollenLITE）：低剂量皮内草花粉免疫治疗季节性变应性鼻炎的双盲随机对照试验
3. Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial [Corrigendum] [J] . Journal of Asthma and Allergy . 2015,第2期

机译：鲁帕他定（10和20 mg）与西替利嗪10 mg在常年性变应性鼻炎中的早晚疗效评估：一项随机，双盲，安慰剂对照试验[更正]
4. Association of Air Pollution with Incidence of Asthma, Allergic Rhinitis and Eczema: 10-Year Follow-Up of the Toronto Child Health Evaluation Questionnaire (T-CHEQ) Study [C] . Teresa To, Natasha Gray, Jingqin Zhu, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：空气污染与哮喘，过敏性鼻炎和湿疹发病率的关联：多伦多儿童健康评估调查表（T-CHEQ）研究的10年随访
5. A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating the Effect of Infliximab on General Cognition in a Population of Depressed Individuals with Bipolar Disorder Type I/II [D] . Pan, Zihang. 2018

机译：一项随机，双盲，安慰剂对照的临床试验，评估英夫利昔单抗对I / II型双相情感障碍抑郁症患者总体认知的影响
6. Morning and evening efficacy evaluation of rupatadine (10 and 20 mg) compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized double-blind placebo-controlled trial Corrigendum [O] . 2015

机译：鲁帕他定（10和20 mg）与西替利嗪10 mg在常年性变应性鼻炎中的早晚疗效评估：一项随机双盲安慰剂对照试验更正
7. Evaluation of the Effect of Lactobacillus paracasei (HF.A00232) in Children (6–13 years old) with Perennial Allergic Rhinitis: A 12-week, Double-blind, Randomized, Placebo-controlled Study [O] . Wen-Ya Lin, Lin-Shien Fu, Heng-Kuei Lin, 2014

机译：评价副干酪乳杆菌（HF.a00232）对多年生过敏性鼻炎患儿（6-13岁）的影响：12周，双盲，随机，安慰剂对照研究

A Double-Blind Controlled Evaluation of Actifed? and its Individual Constituents in Allergic Rhinitis

摘要

著录项

相似文献

相关主题

期刊订阅